Sunny Pharmtech Inc. (TPEX:6676)
Taiwan · Delayed Price · Currency is TWD 17.35
+0.15 (0.87%)
Sep 17, 2025, 1:28 PM CST
Sunny Pharmtech Revenue
In the year 2024, Sunny Pharmtech had annual revenue of 418.01M TWD, down -2.52%. Sunny Pharmtech had revenue of 184.45M in the half year ending December 31, 2024, a decrease of -9.67%.
Revenue
418.01M
Revenue Growth
-2.52%
P/S Ratio
6.12
Revenue / Employee
2.71M
Employees
154
Market Cap
2.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 418.01M | -10.82M | -2.52% |
| Dec 31, 2023 | 428.83M | 69.24M | 19.26% |
| Dec 31, 2022 | 359.59M | 118.59M | 49.21% |
| Dec 31, 2021 | 241.00M | -178.94M | -42.61% |
| Dec 31, 2020 | 419.94M | 185.46M | 79.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 44.83M |
| PharmaEssentia | 12.63B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Lumosa Therapeutics | 37.25M |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Center Laboratories | 1.60B |